Bayer Inc. et al. v Sandoz Canada Inc.

Call to arrange a consultation

2018

T-806-19

Resolved (Interlocutory)

New PM(NOC) Regulations

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,823,159, 2,634,310 and 2,547,113 (rivaroxaban)

Counsel to:

Sandoz Canada Inc.

The decision is reported

Counsel